UBS Group
BCEL

UBS Group’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

UBS Group’s Portfolio BCEL Stock Details BCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,210
Closed -$1.61K – 10310
2023
Q4 		$1.61K Buy
12,210
+5,779
+90% +$1.36K ﹤0.01% 8262
2023
Q3 		$1.68K Sell
6,431
-2,002
-24% -$1.26K ﹤0.01% 7857
2023
Q2 		$8.26K Buy
8,433
+2,002
+31% +$2.06K ﹤0.01% 7251
2023
Q1 		$7.33K Buy
6,431
+1,998
+45% +$2.9K ﹤0.01% 7816
2022
Q4 		$3.55K Buy
4,433
+4,373
+7,288% +$5.56K ﹤0.01% 9495
2022
Q3 		$0 Sell
60
-4,521
-99% -$9.29K ﹤0.01% 11227
2022
Q2 		$8K Sell
4,581
-2,841
-38% -$5.94K ﹤0.01% 8389
2022
Q1 		$23K Sell
7,422
-2,281
-24% -$5.53K ﹤0.01% 7316
2021
Q4 		$29K Buy
9,703
+5,942
+158% +$27.8K ﹤0.01% 7436
2021
Q3 		$23K Sell
3,761
-5,968
-61% -$39.8K ﹤0.01% 7030
2021
Q2 		$83K Sell
9,729
-21,819
-69% -$224K ﹤0.01% 6027
2021
Q1 		$484K Buy
31,548
+30,296
+2,420% +$492K ﹤0.01% 4892
2020
Q4 		$20K Buy
1,252
+629
+101% +$9.43K ﹤0.01% 6961
2020
Q3 		$9K Sell
623
-6,695
-91% -$99.9K ﹤0.01% 6968
2020
Q2 		$156K Sell
7,318
-1,721
-19% -$30.4K ﹤0.01% 4985
2020
Q1 		$150K Sell
9,039
-614
-6% -$11.1K ﹤0.01% 4948
2019
Q4 		$149K Buy
9,653
+3,692
+62% +$44.6K ﹤0.01% 5787
2019
Q3 		$73K Buy
5,961
+4,475
+301% +$68K ﹤0.01% 5964
2019
Q2 		$28K Buy
+1,486
New +$26.8K ﹤0.01% 6391

Other funds holding BCEL

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

UBS Group's BCEL Position: Q1 2024 in Review

UBS Group sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q1 2024, closing a stake of 12,210 shares — an estimated $1.61K sold.

UBS Group first reported a position in BCEL in Q2 2019 and held it in 19 quarters. The position peaked at $484K in Q1 2021. 7 funds tracked by Wall St. Rank hold BCEL as of Q1 2024.

  • UBS Group reported no remaining Atreca, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 12,210 Atreca, Inc. Class A Common Stock shares in Q1 2024, an estimated $1.61K.
  • UBS Group first reported a position in Atreca, Inc. Class A Common Stock in Q2 2019 and held it in 19 quarters.
  • UBS Group's Atreca, Inc. Class A Common Stock position peaked at $484K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.